Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
MoonLake Immunotherapeutics (MLTXN.MX) Q4 2024 Earnings
MLTXN.MX
7
Nov
Confirmed
Q4 2024
-11.08
-10.26
-9.44
-8.62
Details
Expected EPS
-8.618382804800001
Actual EPS
-11.082904000000001
Surprise EPS
-2.46
Surprise Percent
+28.6%
Description
MoonLake Immunotherapeutics (MLTXN.MX) has reported earnings of -11.082904000000001 per share for Q4 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login